We are live on
!
Find out more
WP
Woodline Partners Portfolio holdings
AUM
$26.4B
1-Year Est. Return
44.85%
This Fund
S&P 500
This Quarter
Est. Return
-10.21%
1 Year Est. Return
+44.85%
3 Year Est. Return
+131.23%
5 Year Est. Return
+174.12%
10 Year Est. Return
–
AUM
$6.49B
AUM Growth
+$329M
(+5.3%)
Cap. Flow
+$1.05B
Cap. Flow
% of AUM
16.14%
Top 10 Holdings %
Top 10 Hldgs %
17.7%
Holding
945
New
236
Increased
167
Reduced
92
Closed
153
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$112M |
| 2 |
Skyworks Solutions
SWKS
|
+$103M |
| 3 |
STMicroelectronics
STM
|
+$87.3M |
| 4 |
ASML
ASML
|
+$71.6M |
| 5 |
Palo Alto Networks
PANW
|
+$64.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
SGEN
Seagen Inc. Common Stock
SGEN
|
+$169M |
| 2 |
Cooper Companies
COO
|
+$103M |
| 3 |
ZNGA
ZYNGA INC. CL A COMMON
ZNGA
|
+$102M |
| 4 |
Lam Research
LRCX
|
+$78.9M |
| 5 |
KLA
KLAC
|
+$76.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 34.94% |
| 2 | Technology | 31.31% |
| 3 | Financials | 8.29% |
| 4 | Industrials | 7.52% |
| 5 | Communication Services | 4.71% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
76
Gilead Sciences
GILD
$162B
| $25.8M | 0.4% |
417,963
-3,744
| -0.9% | -$232K |
|
77
Silicon Motion
SIMO
$8.6B
| $25.4M | 0.39% |
+304,000
| New | +$25.6M |
|
78
Synaptics
SYNA
$4.19B
| $25.2M | 0.39% |
+213,153
| New | +$31.2M |
|
79
Baxter International
BAX
$13.5B
| $25.1M | 0.39% |
390,016
-156,329
| -29% | -$11.3M |
|
80
Rogers Corp
ROG
$2.21B
| $24.9M | 0.38% |
94,995
+11,235
| +13% | +$2.99M |
|
|
SJI
81
DELISTED
South Jersey Industries, Inc.
SJI
| $24.1M | 0.37% |
705,801
+158,792
| +29% | +$5.44M |
|
82
Pentair
PNR
$10.4B
| $24M | 0.37% |
524,670
+116,638
| +29% | +$5.84M |
|
83
Boeing
BA
$171B
| $24M | 0.37% |
+175,409
| New | +$25.9M |
|
|
MANT
84
DELISTED
Mantech International Corp
MANT
| $23.6M | 0.36% |
+247,000
| New | +$22.1M |
|
85
On Holding
ONON
$12.1B
| $23.4M | 0.36% |
1,321,398
-28,231
| -2% | -$611K |
|
86
Tyler Technologies
TYL
$12.7B
| $23.3M | 0.36% |
70,168
+46,346
| +195% | +$17M |
|
|
TGNA
87
DELISTED
TEGNA Inc
TGNA
| $22.7M | 0.35% |
1,083,000
+153,000
| +16% | +$3.31M |
|
88
Zai Lab
ZLAB
$2.06B
| $22.4M | 0.35% |
647,262
+355,745
| +122% | +$12.5M |
|
89
Flywire
FLYW
$1.98B
| $22M | 0.34% |
1,246,249
+189,979
| +18% | +$4.41M |
|
90
Dell
DELL
$262B
| $21.8M | 0.34% |
472,099
-681,937
| -59% | -$32.2M |
|
91
Mastercard
MA
$502B
| $21.7M | 0.34% |
+68,908
| New | +$23.7M |
|
|
NVRO
92
DELISTED
NEVRO CORP.
NVRO
| $21.6M | 0.33% |
493,741
+216,860
| +78% | +$11.9M |
|
93
Monolithic Power Systems
MPWR
$70.1B
| $21.5M | 0.33% |
+56,023
| New | +$23.7M |
|
94
Charter Communications
CHTR
$17.3B
| $21.4M | 0.33% |
45,583
+19,498
| +75% | +$9.51M |
|
95
Dollar General
DG
$28B
| $20.7M | 0.32% |
84,458
+65,424
| +344% | +$15.3M |
|
96
T-Mobile US
TMUS
$185B
| $20.4M | 0.31% |
+151,580
| New | +$19.8M |
|
97
Theravance Biopharma
TBPH
$874M
| $20.3M | 0.31% |
2,243,473
+916,820
| +69% | +$8.45M |
|
|
MRTX
98
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $19.7M | 0.3% |
293,567
+167,519
| +133% | +$10.7M |
|
99
Calidi Biotherapeutics
CLDI
$1.98M
| $19.7M | 0.3% |
1,031
| – | – |
|
100
Cigna
CI
$73.7B
| $19.5M | 0.3% |
73,898
-152,237
| -67% | -$39.2M |
|
Similar funds
PAM
TCIIS
UIM
Woodline Partners's Q2 2022 Portfolio in Review
As of Q2 2022, Woodline Partners held 945 positions worth $6.49B, up 5.3% from $6.16B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Woodline Partners deployed $1.05B of net new capital in Q2 2022, opening 236 new positions and adding to 167 existing holdings. Its largest new stake was Skyworks Solutions: 955,660 shares worth $88.5M.
By sector, the portfolio is most concentrated in Healthcare at 35% of assets, down from 39% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Seagen Inc. Common Stock, an estimated $169M trimmed.
- Woodline Partners's largest Q2 2022 buy was Skyworks Solutions: 955,660 shares worth $88.5M.
- Woodline Partners added most to Eli Lilly in Q2 2022, an estimated $112M increase.
- Woodline Partners's biggest Q2 2022 reduction was Seagen Inc. Common Stock, cutting an estimated $169M.
- Woodline Partners fully exited Cooper Companies in Q2 2022, selling an estimated $103M.
- Woodline Partners's ten largest holdings make up 18% of its $6.49B portfolio in Q2 2022.
- Woodline Partners opened 236 new positions and closed 153 in Q2 2022.
- Woodline Partners's portfolio value rose 5.3% quarter-over-quarter to $6.49B.
Based on Woodline Partners's 13F filing for Q2 2022, filed 15 Aug 2022.